Publication Cover
JAPCA Volume 37, 1987 - Issue 9
107
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Acid Particles and the Tracheobronchial Region of the Respiratory System—An “Irritation-Signaling” Model for Possible Health Effects

, , , &
Pages 1060-1066 | Received 19 May 1986, Accepted 05 Mar 1987, Published online: 08 Mar 2012
 

Abstract

This paper explores some detailed mechanistic hypotheses for the possible action of acid particles on the tracheobronchial region of the human respiratory system. Because of the buffering capacity and volume of mucus produced per day it appears doubtful that ordinary ambient exposures to acid particles could markedly change the overall pH of tracheobronchial mucus considered as a whole. However it is possible that individual acidic particles could contain enough acid to deliver localized “irritant signals” that could be the triggers for enhanced mucus secretion and cell division in sensitive portions of the bronchial tree, and thereby contribute to the processes involved in chronic bronchitis.

Depending on the exact pH depression required for a “signal” to be perceived by the tracheobronchial epithelium, the acid content of the incoming particles per unit weight, and the effect of neutralization by ammonia in the upper respiratory tract, the minimum size of an acidic particle required to deliver a perceptible signal might range from about 0.4 to 0.7 microns for portions of the epithelium that are frequently swept by 4-micron mucus droplets. (For unprotected epithelium, however, it is conceivable that the minimum effective size for acid particles could be less.) Since particle number per unit weight declines dramatically with increasing particle size, the most potent fraction of particles in terms of signals delivered per μg/m3is likely to be just above the minimum size that is needed to produce an effective signal. The model developed here makes predictions of the relative potency of particles of different size and acid delivery capacity that could be tested in both experimental animal systems and human epidemiological studies.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.